Minoryx Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 33

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 18

Minoryx General Information

Description

Operator of a biotechnology platform intended to provide innovative treatments for life-threatening rare diseases The company's platform develops therapies focused on a group of diseases of genetic origin with unmet medical needs and discovers a new generation of pharmacological chaperones to restore protein functionality, enabling patients to be relieved from the suffering of orphan diseases.

Contact Information

Website
www.minoryx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Avenida Ernest Lluch 32
  • TecnoCampus Mataró-Maresme 3
  • 08302 Barcelona
  • Spain
+34 935 00 00 00

Minoryx Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Minoryx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Secondary Transaction - Private 00000 Completed Generating Revenue
10. Later Stage VC (Series C) 31-May-2022 000.00 00000 00000 Completed Generating Revenue
9. Debt - General 30-Oct-2020 000.00 000.00 Completed Generating Revenue
8. Later Stage VC (Series B) 20-May-2020 000.00 000.00 000.00 Completed Generating Revenue
7. Grant 09-Apr-2018 00.000 000.00 Completed Generating Revenue
6. Later Stage VC (Series A) 25-Jul-2017 000.00 000.00 000.00 Completed Generating Revenue
5. Later Stage VC 15-Feb-2017 00.000 000.00 000.00 Completed Generating Revenue
4. Seed Round 23-Dec-2014 00.000 00.000 00.000 Completed Generating Revenue
3. Grant 06-Dec-2013 $6.76K $2.07M Completed Generating Revenue
2. Seed Round 02-Apr-2013 $2.07M $2.07M 00.000 Completed Generating Revenue
To view Minoryx’s complete valuation and funding history, request access »

Minoryx Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary 00,000 00.000000 0000.00 0000.00 0000.00 00.000
Ordinary 00,000 00.000000 0000.00 0000.00 0000.00 0.000
Ordinary 00,000 00.000000 0000.00 0000.00 0000.00 00.000
Ordinary 00,000 00.000000 0000.00 0000.00 0000.00 00.000
Ordinary 31,735 $5.434702 $192.72 $192.72 $192.72 16.65%
Ordinary 12,441 $5.434702 $205.31 $205.31 $205.31 6.53%
To view Minoryx’s complete cap table history, request access »

Minoryx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology platform intended to provide innovative treatments for life-threatening rare diseases The co
Drug Discovery
Barcelona, Spain
33 As of 2023
00000
000000 - 000 00000

00000

tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, qui
0000 000000000
Grove City, OH
000 As of 0000
00000
00000000000 00000

000000

tion ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure do
0000 000000000
Dallas, TX
00 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Minoryx Competitors (63)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Forge Biologics Venture Capital-Backed Grove City, OH 000 00000 00000000000 00000
000000 0000 000000 Formerly VC-backed Dallas, TX 00 00000 000000000 00000
0000000000 Venture Capital-Backed Waltham, MA 000 00.000 00000000000 00.000
00000000 Formerly VC-backed San Diego, CA 0 000.00 000000000 000.00
000000 00000000000 Formerly VC-backed Boston, MA 0000 00.000 000000&0
You’re viewing 5 of 63 competitors. Get the full list »

Minoryx Patents

  • 67

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 5

    Granted

  • 4

    Pending

  • 000

    Expiring in next 12 mo

Minoryx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021265345-A1 Leriglitazone for treating lung inflammation and interstitial lung disease Pending 30-Apr-2020 00000000000
CA-3180351-A1 Leriglitazone for treating lung inflammation and interstitial lung disease Pending 30-Apr-2020 00000000000
EP-4142720-A1 Leriglitazone for treating lung inflammation and interstitial lung disease Pending 30-Apr-2020 00000000000
US-20230172921-A1 Leriglitazone for treating lung inflammation and interstitial lung disease Pending 30-Apr-2020 00000000000
AU-2019283649-A1 Method of administering a therapeutically effective amount of 5-((4-(2-(5-(1-hydroxyethyl)pyridin-2-yl)ethoxy)phenyl)methyl)-1,3-thiazolidine-2,4-dione Pending 06-Jun-2018 A61K31/4439
To view Minoryx’s complete patent history, request access »

Minoryx Executive Team (12)

Name Title Board Seat Contact Info
Marc Martinell Ph.D Co-Founder, Chief Executive Officer & Board Member
Sílvia Pascual Director, Clinical Operations
Josep Camps Group Finance Director
Hans Christian Keller Chief Business Officer
Maria Pascual Ph.D Chief Regulatory Officer
You’re viewing 5 of 12 executive team members. Get the full list »

Minoryx Board Members (21)

Name Representing Role Since
Claude Nicaise MD Self Board Member 000 0000
Damià Tormo Self Board Member 000 0000
Géry Lefebvre Société Régionale d'Investissement de Wallonie Board Member 000 0000
Karen Wagner Ph.D Ysios Capital Board Member 000 0000
Khalid Islam Ph.D Self Chairman 000 0000
You’re viewing 5 of 21 board members. Get the full list »

Minoryx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Minoryx Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CDTI Innvierte Government Minority 000 0000 000000 0
Columbus Venture Partners Venture Capital Minority 000 0000 000000 0
Federal Holding and Investment Company Holding Company Minority 000 0000 000000 0
Fund+ Venture Capital Minority 000 0000 000000 0
SambrInvest Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 18 investors. Get the full list »

Ready to get started?

Request a free trial